Literature DB >> 28554754

Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.

Hui Wang1, Feiyan Deng2, Qian Liu1, Yuqing Ma3.   

Abstract

Prediction of lymph node metastasis in esophageal squamous cell carcinoma (ESCC) is very important to have prognostic significance. The objective of this study which involved a relatively large number of ESCC patients was to investigate the correlated factors for lymph node metastasis and prognosis in ESCC. We analyzed a retrospective review of 446 patients with ESCC treated by esophagectomy between January 2010 and July 2016. The relationship between lymph node metastasis and clinicopathological parameters were analyzed. The association between overall survival and clinicopathological factors were evaluated using univariate and multivariable Cox regression models. In the present study, 36.8% esophageal squamous cell carcinoma patients were histologically shown to have lymph node metastasis. Lymph node metastasis was closely correlated with tumor differentiation (p=0.016), perineural invasion (p=0.022), advanced stage tumor (p<0.001) and venous invasion (p<0.001). Kaplan-Meier survival analysis revealed that patients with tumor size, higher T stage, perineuronal invasion, lymph node metastasis, N stage and LNR higher than 0.2 had unfavorable prognosis (p<0.05). The univariate analysis revealed for overall survival that tumor size, pathological stage, perineuronal invasion, lymph metastasis, N stage, involved LNR were relevant prognostic indicators. Furthermore, tumor size, lymph metastasis, N stage and LNR could as independent prognostic factors.
Copyright © 2017. Published by Elsevier GmbH.

Entities:  

Keywords:  Clinicopathological factors; Esophageal squamous cell carcinoma; Lymph node; Perineural invasion; Prognosis

Mesh:

Year:  2017        PMID: 28554754     DOI: 10.1016/j.prp.2017.01.023

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

1.  Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment.

Authors:  Mingxin Zhang; Manli Cui; Qianqian Zuo; Li Wang; Jia Wang; Lin Zhu; Rong Yan; Ning Lu; Honglin Yan; Lingmin Zhang
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Perineural Invasion Is a Significant Indicator of High Malignant Degree and Poor Prognosis in Esophageal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Liuyang Bai; Liangying Yan; Yaping Guo; Luyun He; Zhiyan Sun; Wenbo Cao; Jing Lu; Saijun Mo
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

3.  Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma.

Authors:  Yuan-Ning Guo; Dong-Ping Tian; Qing-Yun Gong; Hao Huang; Peng Yang; Shao-Bin Chen; Salem Billan; Jia-Yu He; Hai-Hua Huang; Pan Xiong; Wen-Ting Lin; Dan Guo; Moshe Marom; Ziv Gil; Min Su
Journal:  Ann Surg Oncol       Date:  2020-06-09       Impact factor: 5.344

4.  Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma.

Authors:  Hui Wang; Yaxing Zhou; Qian Liu; Jiarong Xu; Yuqing Ma
Journal:  Onco Targets Ther       Date:  2018-08-24       Impact factor: 4.147

5.  Genome-wide analysis of long non-coding RNAs in esophageal squamous cell carcinoma reveals their potential role in invasion and metastasis.

Authors:  Jihua Wang; Dianshui Sun; Kai Wu; Jie Liu; Miaoqing Zhao; Xiaomei Li; Ying Xu; Baosheng Li
Journal:  Thorac Cancer       Date:  2018-11-03       Impact factor: 3.500

6.  Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.

Authors:  Zhen Xie; Tianyue Li; Bingtao Huang; Shuai Liu; Lianguo Zhang; Qingguang Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.

Authors:  Jian Zhao; Wei Zhang; Jun Zhang; Yi Zhang; Wen-Jie Ma; Si-Yun Liu; Fu-Yu Li; Bin Song
Journal:  BMC Cancer       Date:  2020-09-03       Impact factor: 4.430

8.  Anti‑metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial‑mesenchymal transition and angiogenesis.

Authors:  Qingtong Shi; Yali Diao; Feng Jin; Zhiyan Ding
Journal:  Mol Med Rep       Date:  2018-05-04       Impact factor: 2.952

9.  MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.

Authors:  Wei-Wei Wang; Zhi-Hua Zhao; Li Wang; Pan Li; Kui-Sheng Chen; Jian-Ying Zhang; Wen-Cai Li; Guo-Zhong Jiang; Xiang-Nan Li
Journal:  EBioMedicine       Date:  2019-08-02       Impact factor: 8.143

10.  Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.

Authors:  Chih-Ming Huang; Chin-Sheng Huang; Tung-Nien Hsu; Mao-Suan Huang; Iat-Hang Fong; Wei-Hwa Lee; Shao-Cheng Liu
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.